Mycobiology

The Korean Society of Mycology (한국균학회)
권호 표지
DOI QR코드

DOI QR Code

The Role of Pentraxin 3 in Aspergillosis: Reality and Prospects

  • Kang, Yuening (Department of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University) ;
  • Yu, Yuetian (Department of Critical Care Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University) ;
  • Lu, Liangjing (Department of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University)
  • Received : 2019.09.22
  • Accepted : 2020.01.23
  • Published : 2020.02.29
Download PDF
⟨ Previous Next ⟩

Abstract

Pentraxin 3 (PTX3) is a soluble pattern recognition receptor (PRR), which is produced by several kinds of cells, such as neutrophils, dendritic cells, macrophages, and epithelial cells. PTX3 is known to play an important protective effect against Aspergillus. Genetic linkage in gene-targeted mice and human PTX3 plays a non-redundant role in the immune protection against specific pathogens, especially Aspergillus. Recent studies have shown that the polymorphism of PTX3 is associated with increased susceptibility to invasive aspergillosis (IA). In this review, we provide an overview of these studies that underline the potential of PTX3 in diagnosis and therapy of IA.

Keywords

References

  1. Alberti C, Bouakline A, Ribaud P, et al. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. J Hosp Infect. 2001;48(3):198-206. https://doi.org/10.1053/jhin.2001.0998
  2. McCormick A, Loeffler J, Ebel F. Aspergillus fumigatus: contours of an opportunistic human pathogen. Cell Microbiol. 2010;12(11):1535-1543. https://doi.org/10.1111/j.1462-5822.2010.01517.x
  3. Taccone F, Van den Abeele A-M, Bulpa P, et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care. 2015;19(1):7. https://doi.org/10.1186/s13054-014-0722-7
  4. Salvatori G, Campo S. Current understanding of PTX3 protective activity on Aspergillus fumigatus infection. Med Mycol. 2012;50(3):225-233. https://doi.org/10.3109/13693786.2011.648215
  5. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011;20(121):156-174. https://doi.org/10.1183/09059180.00001011
  6. Mercier T, Guldentops E, Lagrou K, et al. Galactomannan, a surrogate marker for outcome in invasive aspergillosis: finally coming of age. Front Microbiol. 2018;9:661 https://doi.org/10.3389/fmicb.2018.00661
  7. Garlanda C, Jaillon S, Doni A, et al. PTX3, a humoral pattern recognition molecule at the interface between microbe and matrix recognition. Curr Opin Immunol. 2016;38:39-44. https://doi.org/10.1016/j.coi.2015.11.002
  8. Cunha C, Aversa F, Lacerda JF, et al. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N Engl J Med. 2014;370(5):421-432. https://doi.org/10.1056/NEJMoa1211161
  9. Deban L, Jaillon S, Garlanda C, et al. Pentraxins in innate immunity: lessons from PTX3. Cell Tissue Res. 2011;343(1):237-249. https://doi.org/10.1007/s00441-010-1018-0
  10. Garlanda C, Bottazzi B, Bastone A, et al. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005;23(1):337-366. https://doi.org/10.1146/annurev.immunol.23.021704.115756
  11. Moalli F, Jaillon S, Inforzato A, et al. Pathogen recognition by the long pentraxin PTX3. J Biomed Biotechnol. 2011;2011:830421.
  12. Emsley J, White HE, O'Hara BP, et al. Structure of pentameric human serum amyloid P component. Nature. 1994;367(6461):338-345. https://doi.org/10.1038/367338a0
  13. Rubio N, Sharp PM, Rits M, et al. Structure, expression, and evolution of guinea pig serum amyloid P component and C-reactive protein. J Biochem. 1993;113(3):277-284. https://doi.org/10.1093/oxfordjournals.jbchem.a124039
  14. Abernethy TJ, Avery OT. The occurrence during acute infections of a protein not normally present in the blood: I. Distribution of the reactive protein in patients' sera and the effect of calcium on the flocculation reaction with C polysaccharide of pneumococcus. J Exp Med. 1941;73(2):173-182. https://doi.org/10.1084/jem.73.2.173
  15. Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930;52(4):561-571. https://doi.org/10.1084/jem.52.4.561
  16. Breviario F, d'Aniello EM, Golay J, et al. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem. 1992;267(31):22190-22197. https://doi.org/10.1016/S0021-9258(18)41653-5
  17. Garlanda C, Bottazzi B, Magrini E, et al. PTX3, a humoral pattern recognition molecule, in innate immunity, tissue repair, and cancer. Physiol Rev. 2018;98(2):623-639. https://doi.org/10.1152/physrev.00016.2017
  18. Inforzato A, Rivieccio V, Morreale AP, et al. Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization. J Biol Chem. 2008;283(15):10147-10161. https://doi.org/10.1074/jbc.M708535200
  19. Inforzato A, Baldock C, Jowitt TA, et al. The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2. J Biol Chem. 2010;285(23):17681-17692. https://doi.org/10.1074/jbc.M109.085639
  20. Bonavita E, Gentile S, Rubino M, et al. PTX3 is an extrinsic oncosuppressor regulating complementdependent inflammation in cancer. Cell. 2015;160(4):700-714. https://doi.org/10.1016/j.cell.2015.01.004
  21. Doni A, Musso T, Morone D, et al. An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode. J Exp Med. 2015;212(6):905-925. https://doi.org/10.1084/jem.20141268
  22. Salio M, Chimenti S, De Angelis N, et al. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation. 2008;117(8):1055-1064. https://doi.org/10.1161/CIRCULATIONAHA.107.749234
  23. Jeon H, Lee S, Lee W-H, et al. Analysis of glial secretome: the long pentraxin PTX3 modulates phagocytic activity of microglia. J Neuroimmunol. 2010;229(1-2):63-72. https://doi.org/10.1016/j.jneuroim.2010.07.001
  24. Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med. 2007;204(4):793-804. https://doi.org/10.1084/jem.20061301
  25. Alberti L, Gilardini L, Zulian A, et al. Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors. Atherosclerosis. 2009;202(2):455-460. https://doi.org/10.1016/j.atherosclerosis.2008.05.015
  26. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science. 2010;327(5963):291-295. https://doi.org/10.1126/science.1183021
  27. Jaillon S, Mancuso G, Hamon Y, et al. Prototypic long pentraxin PTX3 is present in breast milk, spreads in tissues, and protects neonate mice from Pseudomonas aeruginosa lung infection. J Immunol. 2013;191(4):1873-1882. https://doi.org/10.4049/jimmunol.1201642
  28. Bottazzi B, Doni A, Garlanda C, et al. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010;28(1):157-183., https://doi.org/10.1146/annurev-immunol-030409-101305
  29. Garred P, Genster N, Pilely K, et al. A journey through the lectin pathway of complement-MBL and beyond. Immunol Rev. 2016;274(1):74-97. https://doi.org/10.1111/imr.12468
  30. Baruah P, Dumitriu IE, Peri G, et al. The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. J Leukoc Biol. 2006;80(1):87-95. https://doi.org/10.1189/jlb.0805445
  31. Kunes P, Holubcova Z, Kolackova M, et al. Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response. Mediators Inflamm. 2012;2012:920517
  32. Moalli F, Doni A, Deban L, et al. Role of complement and Fc{gamma} receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood. 2010;116(24):5170-5180. https://doi.org/10.1182/blood-2009-12-258376
  33. Deban L, Jarva H, Lehtinen MJ, et al. Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation. J Immunol. 2008;181(12):8433-8440. https://doi.org/10.4049/jimmunol.181.12.8433
  34. Ma YJ, Doni A, Hummelshoj T, et al. Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition. J Biol Chem. 2009;284(41):28263-28275. https://doi.org/10.1074/jbc.m109.009225
  35. Lu J, Marnell LL, Marjon KD, et al. Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature. 2008;456(7224):989-992. https://doi.org/10.1038/nature07468
  36. Cotena A, Maina V, Sironi M, et al. Complement dependent amplification of the innate response to a cognate microbial ligand by the long pentraxin PTX3. J Immunol. 2007;179(9):6311-6317. https://doi.org/10.4049/jimmunol.179.9.6311
  37. Wang L, Cano M, Datta S, et al. Pentraxin 3 recruits complement factor H to protect against oxidative stress-induced complement and inflammasome overactivation. J Pathol. 2016;240(4):495-506. https://doi.org/10.1002/path.4811
  38. Ronca R, Alessi P, Coltrini D, et al. Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer. J Pathol. 2013;230(2):228-238. https://doi.org/10.1002/path.4181
  39. Salustri A. PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. Development. 2004; 131(7):1577-1586. https://doi.org/10.1242/dev.01056
  40. Scarchilli L, Camaioni A, Bottazzi B, et al. PTX3 interacts with inter-alpha-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion. J Biol Chem. 2007;282(41):30161-30170. https://doi.org/10.1074/jbc.M703738200
  41. Cappuzzello C, Doni A, Dander E, et al. Mesenchymal stromal cell-derived PTX3 promotes wound healing via fibrin remodeling. J Invest Dermatol. 2016;136(1):293-300. https://doi.org/10.1038/jid.2015.346
  42. Bottazzi B, Santini L, Savino S, et al. Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant. PLoS One. 2015;10(3):e0120807. https://doi.org/10.1371/journal.pone.0120807
  43. Foo S-S, Chen W, Taylor A, et al. Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation. PLoS Pathog. 2015;11(2):e1004649. https://doi.org/10.1371/journal.ppat.1004649
  44. Chabi ML, Goracci A, Roche N, et al. Pulmonary aspergillosis. Diagn Interv Imaging. 2015;96(5):435-442. https://doi.org/10.1016/j.diii.2015.01.005
  45. Gregg KS, Kauffman CA. Invasive aspergillosis: epidemiology, clinical aspects, and treatment. Semin Respir Crit Care Med. 2015;36(5):662-672. https://doi.org/10.1055/s-0035-1562893
  46. Camargo JF, Husain S. Immune correlates of protection in human invasive aspergillosis. Clin Infect Dis. 2014;59(4):569-577. https://doi.org/10.1093/cid/ciu337
  47. Cunha C, Aversa F, Romani L, et al. Human genetic susceptibility to invasive aspergillosis. PLoS Pathog. 2013;9(8):e1003434. https://doi.org/10.1371/journal.ppat.1003434
  48. Cunha C, Di Ianni M, Bozza S, et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipientand donor-dependent mechanisms of antifungal immunity. Blood. 2010;116(24):5394-5402. https://doi.org/10.1182/blood-2010-04-279307
  49. Sun W-K, Lu X, Li X, et al. Dectin-1 is inducible and plays a crucial role in Aspergillus-induced innate immune responses in human bronchial epithelial cells. Eur J Clin Microbiol Infect Dis. 2012;31(10):2755-2764. https://doi.org/10.1007/s10096-012-1624-8
  50. Bruns S, Kniemeyer O, Hasenberg M, et al. Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS Pathog. 2010;6(4):e1000873. https://doi.org/10.1371/journal.ppat.1000873
  51. Diniz SN, Nomizo R, Cisalpino PS, et al. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. J Leukoc Biol. 2004;75(4):649-656. https://doi.org/10.1189/jlb.0803371
  52. Steele C, Rapaka RR, Metz A, et al. The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog. 2005;1(4):e42. https://doi.org/10.1371/journal.ppat.0010042
  53. Garlanda C, Hirsch E, Bozza S, et al. Nonredundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature. 2002;420(6912):182-186. https://doi.org/10.1038/nature01195
  54. Vogl G, Lesiak I, Jensen DB, et al. Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein. Mol Immunol. 2008;45(5):1485-1493. https://doi.org/10.1016/j.molimm.2007.08.011
  55. Fisher CE, Hohl TM, Fan W, et al. Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation. Blood. 2017;129(19):2693-2701. https://doi.org/10.1182/blood-2016-10-743294
  56. Wojtowicz A, Lecompte TD, Bibert S, et al. PTX3 polymorphisms and invasive mold infections after solid organ transplant. Clin Infect Dis. 2015;61(4):619-622. https://doi.org/10.1093/cid/civ386
  57. He Q, Li H, Rui Y, et al. Pentraxin 3 gene polymorphisms and pulmonary aspergillosis in chronic obstructive pulmonary disease patients. Clin Infect Dis. 2018;66(2):261-267. https://doi.org/10.1093/cid/cix749
  58. Cunha C, Monteiro AA, Oliveira-Coelho A, et al. PTX3-based genetic testing for risk of Aspergillosis after lung transplant: Table 1. Clin Infect Dis. 2015;61(12):1893-1894. https://doi.org/10.1093/cid/civ679
  59. D'Angelo C, De Luca A, Zelante T, et al. Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease. J Immunol. 2009;183(7):4609-4618. https://doi.org/10.4049/jimmunol.0900345
  60. de Boer MG, Halkes CJ, van de Vosse E. PTX3 deficiency and aspergillosis. N Engl J Med. 2014;370(17):1665-1666. https://doi.org/10.1056/NEJMc1402787
  61. Morrissey CO, Chen SC-A, Sorrell TC, et al. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect Dis. 2013;13(6):519-528. https://doi.org/10.1016/S1473-3099(13)70076-8
  62. Kabbani D, Bhaskaran A, Singer LG, et al. Pentraxin 3 levels in bronchoalveolar lavage fluid of lung transplant recipients with invasive aspergillosis. J Heart Lung Transplant. 2017;36(9):973-979. https://doi.org/10.1016/j.healun.2017.04.007
  63. Biagi E, Col M, Migliavacca M, et al. PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immunocompromised pediatric patients. J Pediatr Hematol Oncol. 2008;30(12):881-885. https://doi.org/10.1097/MPH.0b013e318180bc1d
  64. Lamaris GA, Lewis RE, Chamilos G, et al. Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis. 2008;198(2):186-192. https://doi.org/10.1086/589305
  65. Simitsopoulou M, Roilides E, Paliogianni F, et al. Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of toll-like receptors. Antimicrob Agents Chemother. 2008;52(9):3301-3306. https://doi.org/10.1128/AAC.01018-07
  66. Bellocchio S, Gaziano R, Bozza S, et al. Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4. J Antimicrob Chemother. 2005;55(2):214-222. https://doi.org/10.1093/jac/dkh542
  67. Gaziano R, Bozza S, Bellocchio S, et al. Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. Antimicrob Agents Chemother. 2004;48(11):4414-4421. https://doi.org/10.1128/AAC.48.11.4414-4421.2004
  68. Lo Giudice P, Campo S, De Santis R, et al. Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2012;56(12):6400-6402. https://doi.org/10.1128/AAC.01000-12

Cited by

  1. The role of pentraxin3 in plasma and bronchoalveolar lavage fluid in COPD patients with invasive pulmonary aspergillosis vol.21, pp.1, 2020, https://doi.org/10.1186/s12890-021-01793-z